Reagents were obtained from the following sources: [3H]-glutamine (GE Healthcare, Amersham, UK); [14C]- α-(methylamino)isobutyric acid (MeAIB; American Radiolabeled Chemicals, Inc., St. Louis, MO); RNA extraction reagent (TRIzol; Invitrogen-Gibco Corp., Grand Island, NY); fetal bovine serum (FBS) (Atlanta Biologicals, Atlanta, GA); an RNA PCR kit (Applied Biosystems, Inc., [ABI] Foster City, CA); a Taq kit (TaKaRa, Tokyo, Japan); rat Müller cells (rMC1; Vijay P. Sarthy, Northwestern University, Chicago, IL). Antibodies used were obtained from the following sources: rabbit anti-GLAST (EAAT1; Alpha Diagnostics, San Antonio, TX); rabbit anti-glutamine synthetase, goat anti-GFAP, goat anti-neurofilament-L (Santa Cruz Biotechnology Inc., Santa Cruz, CA); Cy3-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA); and Alexa Fluor 488-conjugated secondary antibody (Invitrogen, Carlsbad, CA). Anti-CRALBP was a generous gift from John C. Saari (University of Washington, Seattle, WA).